Literature DB >> 17704989

Scientific evidence for a fixed extract combination (Ze 91019) from valerian and hops traditionally used as a sleep-inducing aid.

Axel Brattström1.   

Abstract

Valerian and hops are traditionally used as sleep-inducing aids. Alertness reduces gradually with the prolongation of wakefulness through the release of endogenous adenosine in the frontal basal cortex. Valerian has an adenosine-like action and supports the readiness to fall asleep. The control of the sleep-wake rhythm induces sleep when the time-related interaction is operating properly. The control is closely related to endogenous melatonin secretion. Hops act in a similar way to melatonin. Therefore, the efficacy of a valerian and hops combination in sleep disorder can scientifically be explained.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704989     DOI: 10.1007/s10354-007-0442-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  22 in total

1.  Pharmacological properties of GABAA receptors containing gamma1 subunits.

Authors:  S Khom; I Baburin; E N Timin; A Hohaus; W Sieghart; S Hering
Journal:  Mol Pharmacol       Date:  2005-11-04       Impact factor: 4.436

2.  Evidence that the beta-acids fraction of hops reduces central GABAergic neurotransmission.

Authors:  P Zanoli; M Zavatti; M Rivasi; F Brusiani; G Losi; G Puia; R Avallone; M Baraldi
Journal:  J Ethnopharmacol       Date:  2006-07-11       Impact factor: 4.360

3.  Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release.

Authors:  J G Ortiz; J Nieves-Natal; P Chavez
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

4.  Dual electroencephalogram markers of human sleep homeostasis: correlation between theta activity in waking and slow-wave activity in sleep.

Authors:  L A Finelli; H Baumann; A A Borbély; P Achermann
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

5.  In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors.

Authors:  E A Abourashed; U Koetter; A Brattström
Journal:  Phytomedicine       Date:  2004-11       Impact factor: 5.340

6.  Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons.

Authors:  Z Vissiennon; K Sichardt; U Koetter; A Brattström; K Nieber
Journal:  Planta Med       Date:  2006-04-28       Impact factor: 3.352

7.  Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors.

Authors:  Christa E Müller; Britta Schumacher; Axel Brattström; Ehab A Abourashed; Uwe Koetter
Journal:  Life Sci       Date:  2002-09-06       Impact factor: 5.037

8.  A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder.

Authors:  U Koetter; E Schrader; R Käufeler; A Brattström
Journal:  Phytother Res       Date:  2007-09       Impact factor: 5.878

9.  Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier.

Authors:  M S Santos; F Ferreira; A P Cunha; A P Carvalho; C F Ribeiro; T Macedo
Journal:  Arch Int Pharmacodyn Ther       Date:  1994 Mar-Apr

10.  Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.

Authors:  Britta Schumacher; Silke Scholle; Josef Hölzl; Nasser Khudeir; Sonja Hess; Christa E Müller
Journal:  J Nat Prod       Date:  2002-10       Impact factor: 4.050

View more
  3 in total

1.  Advanced in Vitro Safety Assessment of Herbal Medicines for the Treatment of Non-Psychotic Mental Disorders in Pregnancy.

Authors:  Deborah Spiess; Moritz Winker; Alexandra Dolder Behna; Carsten Gründemann; Ana Paula Simões-Wüst
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

2.  Isolation of a sleep-promoting compound from Polygonatum sibiricum rhizome.

Authors:  Kyungae Jo; Hoon Kim; Hyeon-Son Choi; Seung-Su Lee; Myun-Ho Bang; Hyung Joo Suh
Journal:  Food Sci Biotechnol       Date:  2018-07-13       Impact factor: 2.391

3.  A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.

Authors:  Diana M Taibi; Michael V Vitiello; Suzanne Barsness; Gary W Elmer; Gail D Anderson; Carol A Landis
Journal:  Sleep Med       Date:  2008-05-14       Impact factor: 3.492

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.